PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-68.47%
Negative revenue growth while 0464.HK stands at 16.17%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-65.37%
Negative gross profit growth while 0464.HK is at 139.80%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
6.14%
Operating income growth under 50% of 0464.HK's 77.69%. Michael Burry would be concerned about deeper cost or sales issues.
10.76%
Net income growth under 50% of 0464.HK's 66.96%. Michael Burry would suspect the firm is falling well behind a key competitor.
7.69%
EPS growth under 50% of 0464.HK's 67.14%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
7.69%
Diluted EPS growth under 50% of 0464.HK's 67.14%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Share reduction while 0464.HK is at 0.43%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
49.88%
Positive OCF growth while 0464.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
49.71%
Positive FCF growth while 0464.HK is negative. John Neff would see a strong competitive edge in net cash generation.
-97.45%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-96.44%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-90.02%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
115.36%
10Y OCF/share CAGR above 1.5x 0464.HK's 33.60%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-73.17%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
185.35%
Positive 3Y OCF/share CAGR while 0464.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-313.99%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-501.36%
Negative 5Y net income/share CAGR while 0464.HK is 63.78%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-1283.84%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-28.65%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-32.91%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-33.75%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-70.56%
Firm’s AR is declining while 0464.HK shows 17.81%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-53.13%
Inventory is declining while 0464.HK stands at 14.52%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-11.37%
Negative asset growth while 0464.HK invests at 32.51%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-9.24%
We have a declining book value while 0464.HK shows 69.30%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-20.58%
We’re deleveraging while 0464.HK stands at 46.57%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-67.07%
Our R&D shrinks while 0464.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-20.36%
We cut SG&A while 0464.HK invests at 18.34%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.